A recent study demonstrated that an epidural test dose containing 15 pg epinephrine was an imperfect marker for intravascular injection during isoflurane anesthesia based on the conventional heart rate (HR) criterion (positive if ~20 bpm increase). We have determined the effects of epinephrine doses and isoflurane concentrations on these efficacies in healthy adult patients during isoflurane anesthesia. Eighty patients were randomly assigned to one of four groups according to the simulated test dose injected intravenously (IV) under 1% end-tidal isoflurane and nitrous oxide after endotracheal intubation.
A recent study demonstrated that an epidural test dose containing 15 pg epinephrine was an imperfect marker for intravascular injection during isoflurane anesthesia based on the conventional heart rate (HR) criterion (positive if ~20 bpm increase). We have determined the effects of epinephrine doses and isoflurane concentrations on these efficacies in healthy adult patients during isoflurane anesthesia. Eighty patients were randomly assigned to one of four groups according to the simulated test dose injected intravenously (IV) under 1% end-tidal isoflurane and nitrous oxide after endotracheal intubation.
The saline group (n = 20) received 3 mL normal saline; the epinephrine 7.5 group (n = 20) received 3 mL 1.5% lidocaine containing 7.5 kg epinephrine;
the epinephrine 15 and epinephrine 22.5 groups (n = 20 each) received an identical dose and volume of lidocaine but containing 15 and 22.5 pg epinephrine, respectively. HR and systolic blood pressure (SBP) were monitored invasively for 4 min after IV injection of the study drug. Although none in the saline group developed a HR increase ~20 bpm, 2,14, and 12 patients elicited positive responses in the epinephrine 7.5, 15, and 22.5 groups (lo%, 70%, and 60% sensitivities), respectively. If a positive HR response was defined by an increase of 10 bpm, sensitivities were 55%, lOO%, and 100% in the epinephrine 7.5, 15, and 22.5 groups, respectively. On the other hand, none in the saline group, 12 in the epinephrine 7.5 group, and all patients in the epinephrine 15 and 22.5 groups developed maximum SBP increases 215 mm Hg. An additional 40 patients were randomized to receive isoflurane 0.5% (isoflurane 0.5 group, n = 20) or 1.5% (isoflurane 1.5 group, n = 20), and hemodynamic changes were similarly studied after an IV test dose containing 15 pg epinephrine. Based on the HR criterion ~20 bpm increase, the isoflurane 0.5 and 1.5 groups produced 100% and 30% sensitivities, respectively. Sensitivity of the isoflurane 1.5 group was still 70% based on the modified criterion (~10 bpm increase). All patients in both groups developed SBP increases ~15 mm Hg, giving 100% sensitivities under both isoflurane concentrations. We conclude that under stable isoflurane anesthesia (a) at least 15 pg epinephrine should be used as a test dose, (b) peak HR increase 210 bpm should be regarded as a positive response under ~1% isoflurane, and (c) peak SBP criterion (positive if 215 mm Hg increase) is applicable between 0.5% and 1.5% isoflurane.
(Anesth Analg 1995;81:987-92) E pidural anesthesia from a local anesthetic in combination with general anesthesia is increasingly used for preemptive analgesia. In such cases, only objective hemodynamic symptoms can indicate intravascular migration of the epidural catheter. An inadvertent intravenous (IV) injection of local anesthetic with epinephrine solution could result in serious morbidity and mortality (1, 2) .
Our recent preliminary study (3) demonstrated that a simulated IV injection of 3 mL 1.5% lidocaine plus 15 PLg epinephrine (1:200,000) solution produced 67% sensitivity based on the conventional heart rate (HR) criterion (positive if 220 b pm increase), but 100% sensitivity Accepted for publication June 13, 1995. Address correspondence and reprint requests to Makoto Tanaka, MD, Department of Anesthesia/Critical Care Medicine, Tsuchiura Kyodo General Hospital, 11-7 Manabeshinnmachi, Tsuchiura-shi, Ibaraki-ken 300, Japan. based on the systolic blood pressure (SBP) criterion (positive if ~15 mm Hg increase), both derived from awake, nonpregnant, unmedicated adults (4). However, there are no reports examining the efficacy of epidural test doses in anesthetized patients in a dose-related manner. In general, HR criterion is clinically more useful than SBP as a criterion, since it does not require an invasive arterial cannula. Whether more than 15 pg epinephrine produces better efficacy based on the HR criterion remains unknown. On the other hand, the minimum effective dose of epinephrine which produces 100% sensitivity on SBP criterion has not been determined. Furthermore, these efficacies may be altered by simultaneously administered isoflurane concentrations, since volatile anesthetics are known to reduce the normal electromechanical activity of human atria1 fibers (4) as well as the maximum sinus rate response to epinephrine in a noncompetitive manner (5). 01995 Therefore, the present prospective, randomized, dose-response study was designed to determine sensitivities, specificities, and positive and negative predictive values of epidural test doses containing three different doses of epinephrine, 7.5, 15, and 22.5 pg, in healthy adult patients under a stable course of isoflurane anesthesia. We examined whether the conventional HR and SBP criteria (4) were also applicable with the presence of isoflurane, and, if not, how we should alter the testing regimen to improve the efficacy. In addition, the effects of isoflurane concentrations on the sensitivity of the test dose containing 15 p.g epinephrine were studied.
Methods
The study protocol was approved by our institutional research committee and informed consent was obtained from each patient. One hundred twenty nonpregnant, ASA physical status I patients scheduled to undergo general anesthesia for elective surgeries were studied.
Eighty patients were premeditated with famotidine 20 mg orally 90 min before induction of general anesthesia, and subsequently randomized to one of four groups using computed random numbers: a saline group (n = 201, an epinephrine 7.5-pg group (n = 201, an epinephrine 15-p.g group (n = 20), and an epinephrine 22.5-pg group (n = 20). On arrival at the operating room after 8 h fasting, preinduction blood pressure (BP) and HR were obtained noninvasively.
An arterial cannula was placed in the radial artery after local anesthetic infiltration.
Lactated Ringer's solution was started and maintained at a constant rate of approximately 15 ml-kg-'*h-i throughout the study. After induction of general anesthesia with thiamylal 5 mg/kg IV, endotracheal intubation was facilitated with vecuronium 0.2 mg/kg IV. Anesthesia was then maintained with end-tidal isoflurane 1% and 67% nitrous oxide in oxygen, while ventilation was controlled using a tidal volume of 10 mL/kg and a respiratory rate of 7-9 breaths/min to maintain end-tidal carbon dioxide tension 30-35 mm Hg (5250 RGM; Ohmeda, Louisville, CO). When three measurements of SBP and HR determined at 1-min intervals were within +5% of the previous value, steady 1% end-tidal isoflurane concentration was obtained for 5 min (endtidal isoflurane constantly showing 1% at constant inspiratory concentration), and at least 20 min elapsed after induction of general anesthesia, either normal saline or a simulated epidural test dose containing one of the three different doses of epinephrine was injected IV into a peripheral line of either arm over 3 s. Continuous records of HR and SBP were obtained after injection of the study drug, from which HR and SBP were analyzed at 20-s intervals for 4 min. In addition, maximum HR and SBP responses were noted. Typically, we began hemodynamic measurements 25-30 min after anesthesia induction. The saline group received 3 mL normal saline, the epinephrine 7.5 group received 3 mL 1.5% lidocaine containing 7.5 pg epinephrine, and the epinephrine 15 and 22.5 groups received 3 mL 1.5% lidocaine containing 15 and 22.5 PLg epinephrine, respectively.
The study solutions were prepared as 1.5% lidocaine 20 mL plus 50,100, and 150 p,g epineplirine (0.05,0.1, and 0.15 mL of epinephrine 1 mg/mL) in the epinephrine 7.5,15, and 22.5 groups, respectively, and 3 mL of each 20-mL solution was drawn for injection. They were prepared and coded by the hospital pharmacy. Upon completion of the study and all the data collection, these codes were broken by one of the authors. Both patients and investigators observing hemodynamic changes were blinded to the treatment group of the patients. Arterial blood sampling was performed at the completion of the protocol for analysis of pH CpH,), ho,, Pace,, base excess, potassium and calcium concentrations, and blood glucose value. All hemodynamic measurements and arterial blood samplings were performed before initiation of the patient's scheduled surgery in the supine position.
The premeditation and study protocol were similar to the previous part of the investigation. The additional 40 patients were randomly assigned to either isoflurane 0.5% group or isoflurane 1.5% group (n = 20 each). Both groups received 3 mL 1.5% lidocaine containing 15 pg epinephrine IV, and same hemodynamic measurements were made under stable 0.5% or 1.5% end-tidal isoflurane concentrations as defined previously.
In both parts of the study, preinduction Bl' measurements were made on arrival at the operating room using an automated BP cuff (Life Scope 12; Nihon Koden, Tokyo, Japan). Baseline (preinjection) and subsequent BP measurements after the test dose or saline injections were made using arterial cannulae (Life Scope 12). Standard lead II electrocardiography (Life Scope 12), was monitored continuously throughout the study period, and any arrhythmia was noted. HR was determined from electrocardiography as an average of every 5 s for HR less than 96 bpm, or as an average from RR intervals of 8 consecutive beats for HR more than 96 bpm.
We prospectively defined an increase in HR to be clinically significant (HR criterion) if it was larger than or equal to 20 bpm according to the study by Guinard et al. (4) in which criterion was determined from unmedicated, nonpregnant, awake volunteers. Similarly an increase in SBP greater than or equal to 15 mm Hg was considered a positive test (SBP criterion) (4). The sensitivity and specificity of a positive test in HR and ANESTH ANALG SBP, along with positive and negative predictive values were calculated. All data are expressed as mean + SEM. Patients' demographic and hemodynamic data were compared between groups using the 2 test or two-way analysis of variance followed by unpaired Student's t-test with Bonferroni's correction. Paired hemodynamic data in each group were analyzed by repeated-measures analysis of variance followed by paired Student's t-test with Bonferroni's correction. P < 0.05 was considered the minimum level of statistical significance.
Results
There were no significant differences among the six groups in terms of age, weight, height, gender ratio, preinduction SBP, preinduction diastolic blood pressure, and arterial blood gas and glucose values ( Table  1) . Baseline SBP and diastolic blood pressure immediately before the simulated epidural test dose injection during general anesthesia were also comparable among the groups, and were significantly smaller than the preinduction values within each group (P < 0.01). Baseline HR in the isoflurane 1.5 group was significantly greater than that in isoflurane 0.5 group (P < 0.05). No significant differences in HR were seen between preinduction and baseline values within each group.
IV injection of an epidural test dose containing epinephrine caused significant increases in both HR and SBP, whereas mean values of HR and SBP of the saline group remained essentially unchanged at +-1 bpm and 22 mm Hg throughout the observation period, respectively (data not presented). Significant increases in HR were seen compared with the baseline values in the epinephrine 7.5, 15, and 22.5 groups within intervals of 40-60, 40-80, and 40-60 s after injections, respectively, although significant decreases in HR were observed in the epinephrine 7.5 and 22.5 groups in intervals of 120-220 and 140-180 s, respectively ( Figure  1 ). On the other hand, SBPs were significantly increased compared with the baseline values in the epinephrine 7.5,15, and 22.5 groups between 40-160, 40-220, and 20-240 s, respectively ( Figure  2 ). Mean maximum increments in HR in the epinephrine 7.5,15, and 22.5 groups were 11 ? 2,26 + 2, and 24 + 2 bpm, occurring at 57 5 3, 53 + 2, and 44 + 2 s, whereas those of SBP were 20 zz 2,49 k 5, and 71 k 4 mm Hg, occurring at 70 2 6,97 k 6, and 77 -+ 4 s, respectively. In the epinephrine 7.5, 15, and 22.5 groups (sensitivities lo%, 70%, and 60%), 2,14, and 12 of 20 patients developed maximum HR increments 220 bpm whereas all patients in the saline group had a maximum HR increase ~20 bpm (Table 2) . Therefore, negative predictive values based on the conventional HR criterion of 20 bpm for the intravascular injection in the epinephrine 7.5, 15, and 22.5 groups were 53%, 77%, and 71%, respectively ( Table 2 ). If a positive response was defined by 10 bpm increase in HR, 11, 20, and 20 patients were found to be positive in the epinephrine 7.5, 15, and 22.5 groups, giving sensitivities 55%, lOO%, and lOO%, respectively ( Table 2 ). On REGIONAL ANESTHESIA the other hand, none in the saline group, 12 in the epinephrine 7.5 group, and all of the 20 patients in the epinephrine 15 and 22.5 groups developed maximum SBP increments ~15 mm Hg (SBP criterion), resulting in sensitivities of 60%, lOO%, and lOO%, and negative predictive values of 71%, lOO%, and 100% in the epinephrine 7.5, 15, and 22.5 groups, respectively ( Table  2) . SBP remained increased by 15 mm Hg for 45 + 12 (range, O-230 s), 154 ? 9 (range, 101-213 s), and 177 +-6 s (range, loo-178 s) in the epinephrine 7.5, 15, and 22.5 groups, respectively.
Twenty patients in the isoflurane 0.5 and six patients in the 1.5 group developed HR increases ~20 bpm, giving sensitivities of 100% and 30%, respectively. Even if the HR threshold for a positive response was reduced to a 10 bpm increase, six patients in the isoflurane 1.5 group still had negative responses (70% sensitivity).
On the other hand, all 20 patients in both isoflurane 0.5 and 1.5 groups developed SBP increases 115 mm Hg (100% sensitivities).
SBPs remained increased by 15 mm Hg for 156 +-10 (range, 61-220 s) and 136 + 10 s (range, 80-218 s) in the isoflurane 0.5 and 1.5 groups, respectively.
Plasma potassium and ionized calcium concentrations remained within normal ranges in all the patients. No significant correlations were demonstrated between the maximum changes in HR and body weight, age, epinephrine dose in milligrams per kilogram, or baseline HR within each group. No arrhythmia was observed in any patient throughout the study.
Discussion
The present study has confirmed the results of our previous preliminary observation (3), in which conventional HR criterion (positive if 220 bpm HR increase) did not reliably detect IV injection of lidocaine plus 15 pg epinephrine under stable 1% isoflurane anesthesia. We have shown that such failure did not depend on the dose of epinephrine, but rather on the testing criteria and the isoflurane concentrations.
At 1% end-tidal isoflurane based on the conventional HR criterion, sensitivities did not reach 100% irrespective of the dose of epinephrine.
However, based on the modified HR criterion (positive if ~10 bpm HR increases) or at 0.5% isoflurane concentration, 100% sensitivities were obtained if more than 15 pg epinephrine was used as a test dose. Such modification of the HR criterion seems appropriate under the circumstance of our study, since isoflurane depresses normal electromechanical activity in human atria1 fibers (5) and maximum sinus rate responses to epinephrine (6). Furthermore, stable general anesthetics may reduce the variability in baseline heart rates when compared with awake patients (7), as reflected by the absence of false-positive responses at 1% isoflurane. However, the modified HR criterion may not be even sufficient in the deep plane of isoflurane anesthesia, since the false-negative rate was 30% when end-tidal isoflurane was 1.5%. In addition, whether the modified HR criterion is applicable in older age groups remains to be determined (8, 9) .
In awake, nonpregnant, unpremeditated volunteers, an increase in HR ~20 bpm is 100% sensitive and specific for IV injection of an epidural test dose containing 10 or 15 pg epinephrine (4). However, in the elderly (8, 9) or in patients taking /3-adrenergic blockers (4), SBP changes were more sensitive. The results of our study have important clinical implications, since another group of patients has been identified in which the conventional SBP criterion is more reliable than the conventional HR criterion. In our study, the SBP criterion was applicable even under a deep level of isoflurane anesthesia. In addition, durations of SBP increases by 15 mm Hg seem to last long enough, thus enabling us to detect those clinically significant SBP increments determined by an automated BP cuff used possibly at 1-min intervals. However, one must consider that the error for a single determination of BP with an automated BP cuff may well exceed the threshold of SBP criterion (10). It is not clear whether invasive BP monitorings should be applied in all patients under the combination of epidural analgesia and general anesthesia to detect these transient SBP changes.
In halothane-anesthetized children, a 29% falsenegative rate was noted after an IV test dose of 1% lidocaine with epinephrine (0.5 pg/kg), but the efficacy was improved by atropine pretreatment (11). Isoproterenol has been tested as a marker for IV test dose in children, and found to be more sensitive than epinephrine (12). In newborn lambs anesthetized with halothane, epinephrine produced reliable HR increases only at epinephrine doses greater than 0.5 pg/kg, and only when preceded by atropine (13). Whether these modifications in the testing regimen improve the epidural test dose efficacy in adult patients remains to be determined.
Furthermore, the safety of neuraxial administration of isoproterenol should be examined before use as an epidural test dose in humans.
We are unable to determine why an epidural test dose containing 22.5 pg epinephrine was not associated with better efficacy in HR criterion than 15 pg epinephrine.
A possible explanation is that the larger increase in BP after 22.5 PLg epinephrine may have resulted in more baroreflex slowing of HR ( Figure 2 ). This implies that improvements of efficacy may not be expected simply by increasing the dose of epinephrine. In addition, six (30%) patients in epinephrine 22.5 group developed SBP 2180 mm Hg, whereas two (10%) in the epinephrine 15 and none (0%) in the epinephrine 7.5 groups developed systolic hypertension 2180 mm Hg. Although this degree of hypertension with IV epinephrine 22.5 PLg may not be harmful in otherwise young and healthy subjects, a smaller dose could be quite dangerous in the elderly, or in patients with severe coronary artery disease. We, therefore, do not recommend the use of more than 22.5 pg epinephrine in the epidural test dose, even in healthy young patients, during isoflurane anesthesia.
In clinical situations it is often difficult to detect intravascular migration of the epidural catheter. A clinical decision is sometimes made subjectively. Apart from the fact that the efficacy of the epidural test dose for intravascular injection has not been determined in anesthetized adults, difficulties seem to stem from three causes. First, only a part of local anesthetic may be injected intravascularly.
This could occur if only the tip of the epidural catheter with multiple side eyes migrates into intravascular space. Second, when the epidural block from the local anesthetic is wearing off and a reinforcing dose is clinically required, we could be deceived by a simultaneous 14) reported in laboring women that sensitivity and specificity remained unchanged, even after epidural analgesia from local anesthetic was established. It therefore needs to be emphasized that a "top-up" dose should be given slowly in small incremental doses until a better methodology is established. In conclusion, in adult patients anesthetized with isoflurane and nitrous oxide an epidural test dose consisting of lidocaine and epinephrine remains an imperfect marker of an intravascular injection based on the conventional HR criterion (positive if 220 bpm HR increments), regardless of the dose of epinephrine. Lowering the HR threshold to 10 bpm increments resulted in 100% sensitivity and specificity after 15 or 22.5 pg epinephrine under stable end-tidal isoflurane ~1%. SBP criterion (positive if ~15 mm Hg SBP increment) is applicable using 15 or 22.5 PLg epinephrine in all isoflurane concentrations studied.
